Polytek Development Corp. has announced the acquisition of BCC Products, Inc. Polytek is a portfolio company of Arsenal Capital Partners.
Located in Franklin, Indiana, BCC is a supplier of specialty tooling, mold making, and casting polymers, serving customers across automotive, aerospace, foundry and marine markets. BCC manufactures polyurethane elastomers and resins, CNC tooling board and foam, epoxy, silicone elastomers, and polyester repair materials. BCC also offers custom-formulated polymer systems for applications.
This acquisition fortifies Polytek’s leadership position in industrial mold making and casting solutions and will allow the organization to further serve industries with demanding tooling and casting requirements.
Roger will continue with Polytek and focus on growing the company’s position in the molding and casting industry.
Genesis Capital, LLC acted as the financial advisor to Polytek.
About Polytek Development Corp.
Founded in 1984, Polytek Development Corp. is headquartered in Easton, PA with operations in Pomona, CA and Kalamazoo, MI. Polytek is a manufacturer of specialty polymers including polyurethane elastomers and casting resins, silicone, latex, plastisol, thermoplastic elastomers, and epoxies. These systems are used primarily in mold making and casting applications in industrial, construction, entertainment, arts and crafts, and technology sectors. Divisions of Polytek include California Medical Innovations, Raw Material Suppliers, and Alumilite Corporation.
For more information, visit www.polytek.com.
About BCC Products, Inc.
Founded in 1974 and located in Franklin, IN, BCC Products, Inc. manufactures specialty polymers for tooling, mold making, and casting applications common in automotive, aerospace, foundry and marine industries. Primary product lines include polyurethane elastomers and resins, CNC tooling board and epoxy.
For more information, visit www.bccproducts.com.
About Arsenal Capital Partners
Established in 2000, Arsenal is a private equity firm that specializes in investments in middle-market specialty industrials and healthcare business services companies. Since inception, Arsenal has raised institutional equity investment funds of approximately $3 billion. Arsenal invests in industry sectors in which the firm has significant prior knowledge and experience and seeks companies typically in the range of $100 – $500 million of initial enterprise value.
For more information, visit www.arsenalcapital.com.